ACP6
Basic information
Region (hg38): 1:147629652-147670524
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ACP6 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 23 | 30 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 1 | 23 | 4 | 3 |
Variants in ACP6
This is a list of pathogenic ClinVar variants found in the ACP6 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-147647445-A-G | not specified | Uncertain significance (May 16, 2022) | ||
1-147647504-C-T | not specified | Uncertain significance (Apr 17, 2023) | ||
1-147647506-T-C | Benign (Nov 20, 2018) | |||
1-147648251-C-T | not specified | Uncertain significance (Oct 25, 2023) | ||
1-147648270-A-T | not specified | Uncertain significance (Feb 23, 2023) | ||
1-147648276-C-A | not specified | Uncertain significance (Aug 12, 2021) | ||
1-147650153-C-T | not specified | Likely benign (Mar 07, 2023) | ||
1-147652546-G-A | not specified | Uncertain significance (May 30, 2024) | ||
1-147654205-C-T | not specified | Uncertain significance (Jun 05, 2023) | ||
1-147654208-C-T | not specified | Likely benign (Oct 26, 2022) | ||
1-147654241-C-T | not specified | Uncertain significance (Aug 08, 2022) | ||
1-147654262-T-C | not specified | Likely benign (Sep 26, 2022) | ||
1-147654301-G-C | not specified | Uncertain significance (Oct 29, 2021) | ||
1-147654302-T-C | Benign (Nov 20, 2018) | |||
1-147654314-C-G | not specified | Uncertain significance (Jul 20, 2021) | ||
1-147654322-G-A | not specified | Benign (Mar 06, 2015) | ||
1-147655173-C-T | not specified | Uncertain significance (Aug 09, 2021) | ||
1-147655201-G-A | not specified | Uncertain significance (Oct 30, 2023) | ||
1-147655209-A-C | not specified | Uncertain significance (Nov 27, 2023) | ||
1-147655223-T-G | not specified | Uncertain significance (Mar 20, 2023) | ||
1-147659017-G-A | not specified | Uncertain significance (Aug 16, 2021) | ||
1-147659415-A-T | not specified | Uncertain significance (Oct 25, 2022) | ||
1-147659456-C-T | not specified | Uncertain significance (Apr 08, 2024) | ||
1-147659466-C-T | not specified | Uncertain significance (Dec 17, 2021) | ||
1-147659496-C-T | Cerebral visual impairment and intellectual disability | Likely pathogenic (Sep 09, 2015) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ACP6 | protein_coding | protein_coding | ENST00000369238 | 10 | 41166 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.33e-13 | 0.0347 | 125682 | 0 | 66 | 125748 | 0.000262 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.678 | 206 | 235 | 0.876 | 0.0000117 | 2791 |
Missense in Polyphen | 51 | 50.869 | 1.0026 | 537 | ||
Synonymous | 0.784 | 87 | 96.8 | 0.899 | 0.00000525 | 816 |
Loss of Function | 0.193 | 20 | 21.0 | 0.955 | 8.92e-7 | 249 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000552 | 0.000536 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000711 | 0.000707 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000187 | 0.000185 |
Middle Eastern | 0.000711 | 0.000707 |
South Asian | 0.000491 | 0.000490 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Hydrolyzes lysophosphatidic acid (LPA) containing a medium length fatty acid chain to the corresponding monoacylglycerol. Has highest activity with lysophosphatidic acid containing myristate (C14:0), monounsaturated oleate (C18:1) or palmitate (C16:0), and lower activity with C18:0 and C6:0 lysophosphatidic acid. {ECO:0000269|PubMed:10506173, ECO:0000269|PubMed:23807634}.;
- Pathway
- Vitamin B2 (riboflavin) metabolism;Metabolism of lipids;Metabolism;Glycerophospholipid biosynthesis;Phospholipid metabolism;Synthesis of PA
(Consensus)
Recessive Scores
- pRec
- 0.232
Intolerance Scores
- loftool
- 0.822
- rvis_EVS
- 0.86
- rvis_percentile_EVS
- 88.74
Haploinsufficiency Scores
- pHI
- 0.101
- hipred
- N
- hipred_score
- 0.170
- ghis
- 0.495
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.594
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Acp6
- Phenotype
- normal phenotype;
Gene ontology
- Biological process
- hematopoietic progenitor cell differentiation;phospholipid metabolic process;phosphatidic acid biosynthetic process;dephosphorylation;lysobisphosphatidic acid metabolic process
- Cellular component
- cytoplasm;mitochondrion;mitochondrial matrix
- Molecular function
- acid phosphatase activity;lysophosphatidic acid phosphatase activity